In line with a functional involvement of alternatively activated myeloid cells in influencing tumor burden, the number of CD11b + GR1+ myeloid infiltrates within the tumor tissue of the SORBS2-knockdown group were significantly increased compared with those in the control ID-8 group (Fig. 9a, b). This evidence concerns the gene SORBS2 and neoplasm.